Company profile NRBO
After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0. NeuroBo Pharmaceuticals expected interest is significantly lower compared to previous quarter (-49.6%) and same quarter last year (-53.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 50 | 90 80.0% QoQ | 122 35.6% QoQ | 123 0.8% QoQ |
| 2020 | 111 122.0% YoY -9.8% QoQ | 102 13.3% YoY -8.1% QoQ | 102 -16.4% YoY 0.0% QoQ | 165 34.1% YoY 61.8% QoQ |
| 2021 | 189 70.3% YoY 14.5% QoQ | 134 31.4% YoY -29.1% QoQ | 131 28.4% YoY -2.2% QoQ | 69 -58.2% YoY -47.3% QoQ |
| 2022 | 90 -52.4% YoY 30.4% QoQ | 104 -22.4% YoY 15.6% QoQ | 213 62.6% YoY 104.8% QoQ | 88 27.5% YoY -58.7% QoQ |
| 2023 | 150 66.7% YoY 70.5% QoQ | 151 45.2% YoY 0.7% QoQ | 173 -18.8% YoY 14.6% QoQ | 139 58.0% YoY -19.7% QoQ |
| 2024 | 30 -80.0% YoY -78.4% QoQ | - | - | - |
The average 5 years interest of NeuroBo Pharmaceuticals was 9.68 per week. The last year interest of NeuroBo Pharmaceuticals compared to the last 5 years has changed by 9.81%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 43.65%.
After 39 days of this quarter the interest is at 32.0. Based on that we can calculate that during remaining 52 days it will total up to 75.0. NeuroBo Pharmaceuticals stock expected interest is significantly higher compared to previous quarter (+141.9%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 191 | 132 -30.9% QoQ | 123 -6.8% QoQ | 65 -47.2% QoQ |
| 2020 | 341 78.5% YoY 424.6% QoQ | 129 -2.3% YoY -62.2% QoQ | 159 29.3% YoY 23.3% QoQ | 96 47.7% YoY -39.6% QoQ |
| 2021 | 60 -82.4% YoY -37.5% QoQ | 192 48.8% YoY 220.0% QoQ | 93 -41.5% YoY -51.6% QoQ | 196 104.2% YoY 110.8% QoQ |
| 2022 | 94 56.7% YoY -52.0% QoQ | 80 -58.3% YoY -14.9% QoQ | 49 -47.3% YoY -38.8% QoQ | 226 15.3% YoY 361.2% QoQ |
| 2023 | 67 -28.7% YoY -70.4% QoQ | 136 70.0% YoY 103.0% QoQ | 99 102.0% YoY -27.2% QoQ | 31 -86.3% YoY -68.7% QoQ |
| 2024 | 32 -52.2% YoY 3.2% QoQ | - | - | - |
The average 5 years interest of NeuroBo Pharmaceuticals stock was 9.93 per week. The last year interest of NeuroBo Pharmaceuticals stock compared to the last 5 years has changed by -42.3%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -52.99%.
There is not enough data for NeuroBo Pharmaceuticals news to provide analysis
There is not enough data for NeuroBo Pharmaceuticals news to provide correlation calculation
There is not enough data for NeuroBo Pharmaceuticals news to provide analysis
There is not enough data for NeuroBo Pharmaceuticals clinical-stage biotechnology to provide analysis
There is not enough data for NeuroBo Pharmaceuticals clinical-stage biotechnology to provide correlation calculation
There is not enough data for NeuroBo Pharmaceuticals clinical-stage biotechnology to provide analysis
There is not enough data for DA-1241 to provide analysis
There is not enough data for DA-1241 to provide correlation calculation
There is not enough data for DA-1241 to provide analysis
There is not enough data for G-Protein-Coupled Receptor 119 agonist to provide analysis
There is not enough data for G-Protein-Coupled Receptor 119 agonist to provide correlation calculation
There is not enough data for G-Protein-Coupled Receptor 119 agonist to provide analysis
After 34 days of this quarter the interest is at 271.0. Based on that we can calculate that during remaining 58 days it will total up to 733.0. NASH treatment expected interest is significantly higher compared to previous quarter (+49.6%) and same quarter last year (+64.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 |
| 2022 | 65 inf% YoY inf% QoQ | 554 inf% YoY 752.3% QoQ | 401 inf% YoY -27.6% QoQ | 446 inf% YoY 11.2% QoQ |
| 2023 | 465 615.4% YoY 4.3% QoQ | 570 2.9% YoY 22.6% QoQ | 490 22.2% YoY -14.0% QoQ | 271 -39.2% YoY -44.7% QoQ |
The average 5 years interest of NASH treatment was 12.55 per week. The last year interest of NASH treatment compared to the last 5 years has changed by 215.54%. This is something to be checked. This didn't exist 5 years ago.
There is not enough data for T2D treatment to provide analysis
There is not enough data for T2D treatment to provide correlation calculation
There is not enough data for T2D treatment to provide analysis
There is not enough data for DA-1726 to provide analysis
There is not enough data for DA-1726 to provide correlation calculation
There is not enough data for DA-1726 to provide analysis
There is not enough data for oxyntomodulin analogue to provide analysis
There is not enough data for oxyntomodulin analogue to provide correlation calculation
There is not enough data for oxyntomodulin analogue to provide analysis
There is not enough data for GLP1R/GCGR dual agonist to provide analysis
There is not enough data for GLP1R/GCGR dual agonist to provide correlation calculation
There is not enough data for GLP1R/GCGR dual agonist to provide analysis
After 34 days of this quarter the interest is at 271.0. Based on that we can calculate that during remaining 58 days it will total up to 733.0. NASH treatment expected interest is significantly higher compared to previous quarter (+49.6%) and same quarter last year (+64.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 |
| 2022 | 65 inf% YoY inf% QoQ | 554 inf% YoY 752.3% QoQ | 401 inf% YoY -27.6% QoQ | 446 inf% YoY 11.2% QoQ |
| 2023 | 465 615.4% YoY 4.3% QoQ | 570 2.9% YoY 22.6% QoQ | 490 22.2% YoY -14.0% QoQ | 271 -39.2% YoY -44.7% QoQ |
The average 5 years interest of NASH treatment was 12.55 per week. The last year interest of NASH treatment compared to the last 5 years has changed by 215.54%. This is something to be checked. This didn't exist 5 years ago.
After 39 days of this quarter the interest is at 309.0. Based on that we can calculate that during remaining 52 days it will total up to 721.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 446 | 557 24.9% QoQ | 536 -3.8% QoQ | 543 1.3% QoQ |
| 2020 | 618 38.6% YoY 13.8% QoQ | 605 8.6% YoY -2.1% QoQ | 575 7.3% YoY -5.0% QoQ | 607 11.8% YoY 5.6% QoQ |
| 2021 | 606 -1.9% YoY -0.2% QoQ | 627 3.6% YoY 3.5% QoQ | 564 -1.9% YoY -10.0% QoQ | 613 1.0% YoY 8.7% QoQ |
| 2022 | 829 36.8% YoY 35.2% QoQ | 753 20.1% YoY -9.2% QoQ | 689 22.2% YoY -8.5% QoQ | 799 30.3% YoY 16.0% QoQ |
| 2023 | 867 4.6% YoY 8.5% QoQ | 837 11.2% YoY -3.5% QoQ | 749 8.7% YoY -10.5% QoQ | 907 13.5% YoY 21.1% QoQ |
| 2024 | 309 -64.4% YoY -65.9% QoQ | - | - | - |
The average 5 years interest of obesity treatment was 52.25 per week. The last year interest of obesity treatment compared to the last 5 years has changed by 21.78%. The interest for obesity treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 43.38%.
There is not enough data for ANA001 to provide analysis
There is not enough data for ANA001 to provide correlation calculation
There is not enough data for ANA001 to provide analysis
There is not enough data for oral niclosamide formulation to provide analysis
There is not enough data for oral niclosamide formulation to provide correlation calculation
There is not enough data for oral niclosamide formulation to provide analysis
After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0. COVID-19 treatment expected interest is significantly lower compared to same quarter last year (-48.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 3 | 8 166.7% QoQ | 3 -62.5% QoQ | 3 0.0% QoQ |
| 2020 | 355 11733.3% YoY 11733.3% QoQ | 594 7325.0% YoY 67.3% QoQ | 467 15466.7% YoY -21.4% QoQ | 343 11333.3% YoY -26.6% QoQ |
| 2021 | 287 -19.2% YoY -16.3% QoQ | 196 -67.0% YoY -31.7% QoQ | 409 -12.4% YoY 108.7% QoQ | 307 -10.5% YoY -24.9% QoQ |
| 2022 | 259 -9.8% YoY -15.6% QoQ | 174 -11.2% YoY -32.8% QoQ | 170 -58.4% YoY -2.3% QoQ | 118 -61.6% YoY -30.6% QoQ |
| 2023 | 99 -61.8% YoY -16.1% QoQ | 61 -64.9% YoY -38.4% QoQ | 53 -68.8% YoY -13.1% QoQ | 69 -41.5% YoY 30.2% QoQ |
| 2024 | 22 -77.8% YoY -68.1% QoQ | - | - | - |
The average 5 years interest of COVID-19 treatment was 15.33 per week. The last year interest of COVID-19 treatment compared to the last 5 years has changed by -68.49%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1205.41%.
There is not enough data for NB-01 to provide analysis
There is not enough data for NB-01 to provide correlation calculation
There is not enough data for NB-01 to provide analysis
There is not enough data for painful diabetic neuropathy treatment to provide analysis
There is not enough data for painful diabetic neuropathy treatment to provide correlation calculation
There is not enough data for painful diabetic neuropathy treatment to provide analysis
There is not enough data for NB-02 to provide analysis
There is not enough data for NB-02 to provide correlation calculation
There is not enough data for NB-02 to provide analysis
After 39 days of this quarter the interest is at 79.0. Based on that we can calculate that during remaining 52 days it will total up to 184.0. cognitive impairment treatment expected interest is significantly lower compared to previous quarter (-69.5%) and same quarter last year (-62.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 97 | 417 329.9% QoQ | 143 -65.7% QoQ | 209 46.2% QoQ |
| 2020 | 260 168.0% YoY 24.4% QoQ | 194 -53.5% YoY -25.4% QoQ | 202 41.3% YoY 4.1% QoQ | 447 113.9% YoY 121.3% QoQ |
| 2021 | 254 -2.3% YoY -43.2% QoQ | 230 18.6% YoY -9.4% QoQ | 226 11.9% YoY -1.7% QoQ | 222 -50.3% YoY -1.8% QoQ |
| 2022 | 340 33.9% YoY 53.2% QoQ | 301 30.9% YoY -11.5% QoQ | 372 64.6% YoY 23.6% QoQ | 431 94.1% YoY 15.9% QoQ |
| 2023 | 485 42.6% YoY 12.5% QoQ | 308 2.3% YoY -36.5% QoQ | 301 -19.1% YoY -2.3% QoQ | 603 39.9% YoY 100.3% QoQ |
| 2024 | 79 -83.7% YoY -86.9% QoQ | - | - | - |
The average 5 years interest of cognitive impairment treatment was 23.45 per week. The last year interest of cognitive impairment treatment compared to the last 5 years has changed by 28.74%. The interest for cognitive impairment treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 60.67%.
After 39 days of this quarter the interest is at 193.0. Based on that we can calculate that during remaining 52 days it will total up to 450.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 246 | 456 85.4% QoQ | 374 -18.0% QoQ | 360 -3.7% QoQ |
| 2020 | 389 58.1% YoY 8.1% QoQ | 326 -28.5% YoY -16.2% QoQ | 332 -11.2% YoY 1.8% QoQ | 372 3.3% YoY 12.0% QoQ |
| 2021 | 290 -25.4% YoY -22.0% QoQ | 297 -8.9% YoY 2.4% QoQ | 246 -25.9% YoY -17.2% QoQ | 507 36.3% YoY 106.1% QoQ |
| 2022 | 385 32.8% YoY -24.1% QoQ | 405 36.4% YoY 5.2% QoQ | 367 49.2% YoY -9.4% QoQ | 417 -17.8% YoY 13.6% QoQ |
| 2023 | 466 21.0% YoY 11.8% QoQ | 461 13.8% YoY -1.1% QoQ | 372 1.4% YoY -19.3% QoQ | 513 23.0% YoY 37.9% QoQ |
| 2024 | 193 -58.6% YoY -62.4% QoQ | - | - | - |
The average 5 years interest of tau protein was 29.79 per week. The last year interest of tau protein compared to the last 5 years has changed by 17.05%. The interest for tau protein is trending. The last year interest is comparable to 5 years ago. It has changed only by 13.47%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Gemcabene expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 147 | 122 -17.0% QoQ | 133 9.0% QoQ | 229 72.2% QoQ |
| 2020 | 226 53.7% YoY -1.3% QoQ | 27 -77.9% YoY -88.1% QoQ | 114 -14.3% YoY 322.2% QoQ | 104 -54.6% YoY -8.8% QoQ |
| 2021 | 159 -29.6% YoY 52.9% QoQ | 190 603.7% YoY 19.5% QoQ | 168 47.4% YoY -11.6% QoQ | 148 42.3% YoY -11.9% QoQ |
| 2022 | 260 63.5% YoY 75.7% QoQ | 151 -20.5% YoY -41.9% QoQ | 121 -28.0% YoY -19.9% QoQ | 163 10.1% YoY 34.7% QoQ |
| 2023 | 88 -66.2% YoY -46.0% QoQ | 360 138.4% YoY 309.1% QoQ | 77 -36.4% YoY -78.6% QoQ | 131 -19.6% YoY 70.1% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Gemcabene was 11.95 per week. The last year interest of Gemcabene compared to the last 5 years has changed by -0.59%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -14.1%.
After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0. COVID-19 treatment expected interest is significantly lower compared to same quarter last year (-48.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 3 | 8 166.7% QoQ | 3 -62.5% QoQ | 3 0.0% QoQ |
| 2020 | 355 11733.3% YoY 11733.3% QoQ | 594 7325.0% YoY 67.3% QoQ | 467 15466.7% YoY -21.4% QoQ | 343 11333.3% YoY -26.6% QoQ |
| 2021 | 287 -19.2% YoY -16.3% QoQ | 196 -67.0% YoY -31.7% QoQ | 409 -12.4% YoY 108.7% QoQ | 307 -10.5% YoY -24.9% QoQ |
| 2022 | 259 -9.8% YoY -15.6% QoQ | 174 -11.2% YoY -32.8% QoQ | 170 -58.4% YoY -2.3% QoQ | 118 -61.6% YoY -30.6% QoQ |
| 2023 | 99 -61.8% YoY -16.1% QoQ | 61 -64.9% YoY -38.4% QoQ | 53 -68.8% YoY -13.1% QoQ | 69 -41.5% YoY 30.2% QoQ |
| 2024 | 22 -77.8% YoY -68.1% QoQ | - | - | - |
The average 5 years interest of COVID-19 treatment was 15.33 per week. The last year interest of COVID-19 treatment compared to the last 5 years has changed by -68.49%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1205.41%.